TAMPELLINI, MARCO

TAMPELLINI, MARCO  

ONCOLOGIA  

Mostra records
Risultati 1 - 20 di 24 (tempo di esecuzione: 0.179 secondi).
Titolo Data di pubblicazione Autore(i) File
Changes in body composition after androgen deprivation therapy (ADT) in prostate cancer patients. Relationship with disease outcome 2008 A. Berruti; F. Vana; M. Tucci; A. Mosca; L. Russo; G. Gorzegno; A. Saini; P. Perotti; M. Tampellini; L. Dogliotti
Chirurgia delle metastasi polmonari da carcinoma colo-rettale: una serie di 171 pazienti. 2014 Luca Errico; Elena Lisi; Elena Asteggiano; Matteo Gagliasso; Nicola Liberato; Corrado Novello; Marco Tampellini; Francesco Ardissone
Chronomodulated delivery schedule of Oxaliplatin (OHP), 5-Fluorouracil and Folinic Acid (FFL4/10) allows to increase significantly dose intensity rate of OHP based schedule: 2 years experience in gastrointestinal cancers 2004 Masseroni S; Pirovano M; Nasisi A; Biffi A; Romanelli A; Sestini S; Valsecchi R; Martignoni G; Tabiadon D; Tampellini M
Circadian rhythm of bone turnover markers in breast cancer patients with bone metastases and in control subjects 2005 D. G. Generali; S. Tedoldi; M. Tampellini; A. Berruti; M. Torta; S. Bonardi; A. Bottini; M. Tucci; M. Milani; A. Angeli; L. Dogliotti
CIRCADIAN RHYTHM OF BONE TURNOVER MARKERS INBREAST CANCER PATIENTS WITH METASTATIC BONE DISEASE ANDIN CONTROL SUBJECTS 2004 Daniele Generali; Sara Tedoldi; Alberto Bottini; Alfredo Berruti; Marco Tampellini; Marcello Tucci; Giovanni Allevi; Mirella Torta; Simone Bonardi; Manuela Milani; Sergio Aguggini; Alberto Angeli; Luigi Dogliotti
Circadian rhythm of breakthrough cancer pain. 2011 A. Saini; M. Tucci; K. Bouraouia; P. Ghio; M. Tampellini; P. M. Furlan; L. Ostacoli; L. Dogliotti; A. Berruti
Effect of zoledronic acid (Z) treatment based on serum parathyroid hormone (PTH) levels in patients (pts) with malignant bone disease. 2006 Berruti A; Dogliotti L; Tampellini M; Lipton A; Hirsh V; Saad F; Liati P; Shirina N; Cook R; Hei YL
GENDER-DEPENDENT OPTIMAL SCHEDULING OFCANCER CHRONOTHERAPEUTICS 2006 F. Levi; S. Giacchetti; G. Bjarnason; C. Focan; D. Genet; S. Iacobelli; M. Tampellini; R. Smaaland; T. Gorlia; C. Garufi
Increased antiresorptive activity of zoledronic acid (Z) administered in the night as compared to morning administration in breast cancer (BC) patients with bone metastases. 2006 Bottini A; Generali D; Berruti A; Tampellini M; Torta M; Tedoldi S; Bonardi S; Tucci M; Gorzegno G; Dogliotti L
INCREASED NUMBER OF NEUROENDOCRINE CELLS IN METASTATIC COLORECTAL ADENOCARCINOMA FOLLOWING CHEMO/RADIOTHERAPY 2007 Snezana Andrejevic-Blant; Marco Tampellini; Luisella Righi; Irene Alabiso; Veronica Tavaglione; Marco Volante; Luigi Dogliotti; Mauro Papotti; Valerio Marci
LONG-TERM SURVIVAL OF PATIENTS WITH RESECTION OF PULMONARY METASTASES FROM COLORECTAL NEOPLASMS AS COMPARED TO NOT RESECTED ONES. A RETROSPECTIVE STUDY ON PATIENTS FOLLOWED FROM THE TIME OF FIRST RECURRENCE 2011 Marco Tampellini; Azzurra Ottone; Elisa Bellini; Irene Alabiso; Francesco Leone; Stefania Miraglia; Oscar Alabiso; Massimo Aglietta; Luigi Dogliotti
NATURAL HISTORY OF MALIGNANT BONE DISEASE IN COLORECTAL CANCER: FINAL RESULTS OF A LARGE ITALIAN "BONE METASTASES" SURVEY 2010 Santini D; Tampellini M; Barni S; Silvestris N; Maiello E; Calipari N; Ibrahim T; Catalano V; Vincenzi B; Tonini G
Natural history of malignant bone disease in colorectal cancer: Final results of a large Italian “bone metastases” survey 2011 D. Santini; S. Barni; M. Tampellini; N. Silvestris; E. Maiello; N. Calipari; T. Ibrahim; V. Catalano; B. Vincenzi; G. Tonini
PHASE II TRIAL OF PANITUMUMAB IN COMBINATION WITH OXALIPLATIN AND CAPECITABINE CHEMOTHERAPY AS 1ST LINE THERAPY IN PATIENTS WITH COLORECTAL CANCER AND ADVANCED LIVER METASTASES: THE METAPAN STUDY 2012 Leone F; Marino D; Artale S; Cagnazzo C; Cascinu S; Martoni AA; Sobrero A; Tampellini M; Siena S; Aglietta M
Predictive factors for skeletal complications in prostate cancer patients with hormone refractory disease 2005 M. Tucci; A. Berruti; A. Mosca; F. Vana; G. La Manna; L. Russo; M. Poggio; R. Bitossi; G. Gorzegno; M. Tampellini; A. Saini
Prognostic factors in advanced colorectal carcinoma: A multifactorial analysis 2005 L. Forti; S. Miraglia; E. Bertona; V. Rossi; D. Rondonotti; M. Tampellini; G. Porcile; O. Alabiso
Role of surgical resection in colorectal lung metastases: analysis of 137 patients 2009 Borasio P; Gisabella M; Billè A; Righi L; Tampellini M; Ardissone F.
Survival of lung surgery patients with pulmonary metastases from colonic neoplasms 2008 M. Tampellini; I. Alabiso; A. Ottone; S. Miraglia; L. Forti; E. Bertona; C. M. Sculli; E. Bellini; O. Alabiso; L. Dogliotti
TGFalfa, EGFR and p70S6K expression in aggressive colorectal cancer (CRC) 2006 M. Tampellini; M. Longo; S. Cappia; E. Bacillo; M. Brizzi; R. Bitossi; C. M. Sculli; I. Alabiso; L. Dogliotti; M. Papotti
The circadian rhythm of biochemical markers of bone resorption is normally synchronized in breast cancer patients with bone lytic metastases independently of tumor load. 2006 A Dovio; D Generali; A Berruti; M Tampellini; S Tedoldi; S Bonardi; M Tucci; G Allevi; S Aguggini; M Milani; A Bottini; L Dogliotti; A Angeli